Department of Psychiatry, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Department of Psychiatry, Brain Hospital of Hunan Province (The Second People's Hospital of Hunan Province), Changsha, Hunan, China.
Front Immunol. 2024 Feb 6;15:1341596. doi: 10.3389/fimmu.2024.1341596. eCollection 2024.
BACKGROUND: Tumor vaccines have become crucial in cancer immunotherapy, but, only a limited number of phase III clinical trials have demonstrated clinical efficacy. The crux of this issue is the inability of tumor vaccines to effectively harmonize the tumor microenvironment with its intricate interplay. One factor that can hinder the effectiveness of vaccines is the natural immunosuppressive element present in the tumor microenvironment. This element can lead to low rates of T-cell response specific to antigens and the development of acquired resistance. Conversely, anticancer vaccines alter the tumor microenvironment in conflicting manners, inducing both immune activation and immunological evasion. Hence, comprehending the correlation between tumor vaccines and the tumor microenvironment would establish a foundation for forthcoming tumor treatment. OBJECTIVE: Our review explores the realm of research pertaining to tumor vaccinations and the tumor microenvironment. Our objective is to investigate the correlation between tumor vaccines and the tumor microenvironment within this domain. We then focus our review on the dominant international paradigms in this research field and visually illustrates the historical progression and emergent patterns observed in the past. METHODS: From January 1, 1999 to February 7, 2023, 1420 articles on the interplay between tumor vaccines and the tumor microenvironment were published, according to The Clarivate Web of Science (WOS) database used in our review. A bibliometric review was designed for this collection and consisted of an evaluation. The evaluation encompassed various discernible attributes, including the year of publication, the journals in which the articles were published, the authors involved, the affiliated institutions, the geographical locations of the institutions, the references cited, and the keywords employed. RESULTS: Between the years 1999 and 2022, publications saw a significant increase, from 3 to 265 annually. With 72 papers published, Frontiers in Immunology had the most manuscripts published. The Cancer Research publication garnered the highest number of citations, amounting to 2874 citations. The United States exerts significant dominance in the subject, with the National Cancer Institute being recognized as a prominent institution in terms of both productivity and influence. Furthermore, Elizabeth M. Jaffee was recognized as the field's most prolific and influential author with 24 publications and 1,756 citations. The co-occurrence cluster analysis was conducted on the top 197 keywords, resulting in the identification of five distinct clusters. The most recent high-frequency keywords, namely immune therapy, dendritic cell, tumor microenvironment, cancer, and vaccine, signify the emerging frontiers in the interaction between tumor vaccines and the tumor microenvironment. CONCLUSION: Our review uncovers insights into contemporary trends, global patterns of collaboration, fundamental knowledge, research areas of high interest, and emerging frontiers in the field of TME-targeted vaccines.
背景:肿瘤疫苗已成为癌症免疫疗法的关键,但只有少数三期临床试验显示出临床疗效。问题的关键在于肿瘤疫苗无法有效地协调肿瘤微环境及其错综复杂的相互作用。一个可能阻碍疫苗有效性的因素是肿瘤微环境中存在的天然免疫抑制因素。这一因素可能导致针对抗原的 T 细胞反应率低,并产生获得性耐药性。相反,抗癌疫苗以相互冲突的方式改变肿瘤微环境,诱导免疫激活和免疫逃避。因此,了解肿瘤疫苗与肿瘤微环境之间的相关性将为未来的肿瘤治疗奠定基础。
目的:本综述探讨了肿瘤疫苗与肿瘤微环境领域的研究。我们的目标是研究肿瘤疫苗与肿瘤微环境之间的相关性。然后,我们将重点关注该研究领域的主导国际范式,并直观地展示过去的历史进展和新兴模式。
方法:根据我们综述中使用的 Clarivate Web of Science (WOS) 数据库,从 1999 年 1 月 1 日至 2023 年 2 月 7 日,共发表了 1420 篇关于肿瘤疫苗与肿瘤微环境相互作用的文章。对这一集合进行了文献计量学综述,包括评估。评估涵盖了各种可识别的属性,包括出版年份、发表文章的期刊、作者、所属机构、机构的地理位置、参考文献和使用的关键词。
结果:1999 年至 2022 年间,出版物数量显著增加,从每年 3 篇增加到 265 篇。Frontiers in Immunology 发表的论文最多,有 72 篇。Cancer Research 的引用次数最多,为 2874 次。美国在该领域占据显著优势,国家癌症研究所是生产力和影响力方面的知名机构。此外,Elizabeth M. Jaffee 被认为是该领域最有影响力的作者,共发表了 24 篇论文,被引次数为 1756 次。对前 197 个关键词进行共现聚类分析,共分为 5 个不同的簇。最近出现的高频关键词,如免疫疗法、树突状细胞、肿瘤微环境、癌症和疫苗,标志着肿瘤疫苗与肿瘤微环境相互作用的新兴前沿。
结论:本综述揭示了当代趋势、全球合作模式、基础知识、高关注研究领域和 TME 靶向疫苗领域的新兴前沿。
Front Immunol. 2023
Cancer Rep (Hoboken). 2024-8
Hum Vaccin Immunother. 2024-12-31
J Control Release. 2022-5
Front Immunol. 2023
Vaccines (Basel). 2025-4-27
Perioper Med (Lond). 2025-3-17
Front Aging Neurosci. 2024-8-30
Support Care Cancer. 2024-7-23
Vaccines (Basel). 2023-9-7
J Hematol Oncol. 2023-7-6
Cells. 2023-4-12
Int Immunopharmacol. 2022-12
Int Immunopharmacol. 2022-12